LHX5
gene geneOn this page
Summary
LHX5 (LIM homeobox 5, HGNC:14216) is a protein-coding gene on chromosome 12q24.13, encoding LIM/homeobox protein Lhx5 (Q9H2C1). Plays an essential role in the regulation of neuronal differentiation and migration during development of the central nervous system.
This gene encodes a protein belonging to a large protein family, members of which carry the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein may function as a transcriptional regulator and be involved in the control of differentiation and development of the forebrain. In mice, this protein is essential for the regulation of precursor cell proliferation and the control of neuronal differentiation and migration during hippocampal development. This protein is involved in learning and motor functions in adult mice.
Source: NCBI Gene 64211 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 44 total
- MANE Select transcript:
NM_022363
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14216 |
| Approved symbol | LHX5 |
| Name | LIM homeobox 5 |
| Location | 12q24.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000089116 |
| Ensembl biotype | protein_coding |
| OMIM | 605992 |
| Entrez | 64211 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000261731, ENST00000557836
RefSeq mRNA: 1 — MANE Select: NM_022363
NM_022363
CCDS: CCDS9171
Canonical transcript exons
ENST00000261731 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000563040 | 113467256 | 113467421 |
| ENSE00000755547 | 113468127 | 113468404 |
| ENSE00000755548 | 113469122 | 113469345 |
| ENSE00000834995 | 113462033 | 113463557 |
| ENSE00000834996 | 113471326 | 113471871 |
Expression profiles
Bgee: expression breadth broad, 30 present calls, max score 73.77.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.8546 / max 82.7549, expressed in 116 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 133368 | 0.6777 | 105 |
| 133367 | 0.1769 | 51 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 73.77 | gold quality |
| medial globus pallidus | UBERON:0002477 | 67.02 | gold quality |
| hypothalamus | UBERON:0001898 | 63.25 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 62.12 | gold quality |
| globus pallidus | UBERON:0001875 | 61.39 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.30 | gold quality |
| cerebellar cortex | UBERON:0002129 | 59.71 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 59.53 | gold quality |
| cartilage tissue | UBERON:0002418 | 58.84 | gold quality |
| cerebellum | UBERON:0002037 | 58.56 | gold quality |
| heart right ventricle | UBERON:0002080 | 57.81 | gold quality |
| parotid gland | UBERON:0001831 | 56.94 | gold quality |
| inferior olivary complex | UBERON:0002127 | 54.81 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 54.56 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 54.45 | gold quality |
| body of stomach | UBERON:0001161 | 53.99 | gold quality |
| myocardium | UBERON:0002349 | 52.65 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 52.50 | gold quality |
| stomach | UBERON:0000945 | 50.84 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| nephron tubule | UBERON:0001231 | 47.50 | gold quality |
| periodontal ligament | UBERON:0008266 | 47.14 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 47.07 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 46.87 | gold quality |
| renal glomerulus | UBERON:0000074 | 46.86 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 46.77 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 46.47 | gold quality |
| fundus of stomach | UBERON:0001160 | 46.22 | gold quality |
| substantia nigra | UBERON:0002038 | 46.16 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8894 | yes | 419.68 |
| E-HCAD-5 | yes | 409.33 |
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| GNRHR |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1519.1 | LHX5 | HD-LIM |
| MA1519.2 | LHX5 | HD-LIM |
JASPAR matrix evidence (PMIDs): PMID:18585359
miRNA regulators (miRDB)
7 targeting LHX5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-133A-3P | 99.27 | 71.53 | 1270 |
| HSA-MIR-133B | 99.27 | 71.53 | 1270 |
| HSA-MIR-485-5P | 99.10 | 64.78 | 1889 |
| HSA-MIR-6884-5P | 99.10 | 64.50 | 1987 |
| HSA-MIR-6499-5P | 87.01 | 61.21 | 38 |
| HSA-MIR-579-5P | 81.13 | 62.60 | 10 |
Literature-anchored findings (GeneRIF, showing 3)
- In mice, this protein is essential for the regulation of precursor cell proliferation and the control of neuronal differentiation and migration during hippocampal development. (PMID:10325223)
- In mice, this protein is involved in learning and motor functions. (PMID:11566211)
- Variation is not a highly penetrant autosomal dominant susceptibility locus for mood disorder in families. (PMID:12782966)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lhx5 | ENSMUSG00000029595 |
| rattus_norvegicus | Lhx5 | ENSRNOG00000001392 |
Paralogs (20): FHL1 (ENSG00000022267), LMO3 (ENSG00000048540), ZFHX4 (ENSG00000091656), LHX2 (ENSG00000106689), LHX6 (ENSG00000106852), LHX3 (ENSG00000107187), LHX4 (ENSG00000121454), LMO2 (ENSG00000135363), ZFHX2 (ENSG00000136367), LMX1B (ENSG00000136944), ZFHX3 (ENSG00000140836), LMO4 (ENSG00000143013), LHX9 (ENSG00000143355), CRIP3 (ENSG00000146215), LHX8 (ENSG00000162624), LMX1A (ENSG00000162761), LMO1 (ENSG00000166407), CRIP2 (ENSG00000182809), CRIP1 (ENSG00000213145), LHX1 (ENSG00000273706)
Protein
Protein identifiers
LIM/homeobox protein Lhx5 — Q9H2C1 (reviewed: Q9H2C1)
All UniProt accessions (1): Q9H2C1
UniProt curated annotations — full annotation on UniProt →
Function. Plays an essential role in the regulation of neuronal differentiation and migration during development of the central nervous system.
Subcellular location. Nucleus.
Tissue specificity. Expressed in fetal brain and in various regions of the adult central nervous system including the spinal cord, the thalamus, and the cerebellum.
RefSeq proteins (1): NP_071758* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR001781 | Znf_LIM | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR049618 | Lhx1/5_LIM1 | Domain |
| IPR049619 | Lhx1/5_LIM2 | Domain |
| IPR050453 | LIM_Homeobox_TF | Family |
Pfam: PF00046, PF00412
UniProt features (10 total): compositionally biased region 4, domain 2, region of interest 2, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H2C1-F1 | 68.12 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
GOBP_SPINAL_CORD_DEVELOPMENT, GOBP_HINDBRAIN_DEVELOPMENT, GOBP_METENCEPHALON_DEVELOPMENT, BENPORATH_ES_WITH_H3K27ME3, E2F4DP1_01, GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION, GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS, GOBP_NEUROGENESIS, FOXO1_01, CHX10_01, GOBP_CELL_PROLIFERATION_IN_FOREBRAIN, GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD, GOBP_FOREBRAIN_DEVELOPMENT, GOBP_CELL_CELL_SIGNALING, GOBP_FOREBRAIN_GENERATION_OF_NEURONS
GO Biological Process (15): regulation of transcription by RNA polymerase II (GO:0006357), neuroblast proliferation (GO:0007405), spinal cord association neuron differentiation (GO:0021527), cerebellar Purkinje cell differentiation (GO:0021702), hippocampus development (GO:0021766), cell proliferation in forebrain (GO:0021846), forebrain neuron differentiation (GO:0021879), regulation of cerebellar granule cell precursor proliferation (GO:0021936), cerebellar Purkinje cell-granule cell precursor cell signaling (GO:0021937), neuron differentiation (GO:0030182), positive regulation of DNA-templated transcription (GO:0045893), regulation of neuroblast proliferation (GO:1902692), regulation of DNA-templated transcription (GO:0006355), cell-cell signaling (GO:0007267), cerebellum development (GO:0021549)
GO Molecular Function (8): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| central nervous system neuron differentiation | 3 |
| regulation of DNA-templated transcription | 2 |
| generation of neurons | 2 |
| neural precursor cell proliferation | 2 |
| anatomical structure development | 2 |
| regulation of neural precursor cell proliferation | 2 |
| DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| cell differentiation in spinal cord | 1 |
| dorsal spinal cord development | 1 |
| cell differentiation in hindbrain | 1 |
| cerebellar Purkinje cell layer formation | 1 |
| pallium development | 1 |
| limbic system development | 1 |
| forebrain development | 1 |
| forebrain generation of neurons | 1 |
| cerebellar granule cell precursor proliferation | 1 |
| cell-cell signaling | 1 |
| cell differentiation | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| neuroblast proliferation | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cell communication | 1 |
| signaling | 1 |
| metencephalon development | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1048 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LHX5 | BARHL1 | Q9BZE3 | 619 |
| LHX5 | DBX1 | A6NMT0 | 552 |
| LHX5 | PAX2 | Q02962 | 522 |
| LHX5 | LDB1 | Q86U70 | 522 |
| LHX5 | EMX2 | Q04743 | 518 |
| LHX5 | FEZF1 | A0PJY2 | 503 |
| LHX5 | PTF1A | Q7RTS3 | 494 |
| LHX5 | SIX3 | O95343 | 481 |
| LHX5 | EMX1 | Q04741 | 478 |
| LHX5 | LDB2 | O43679 | 477 |
| LHX5 | NKX2-1 | P43699 | 476 |
| LHX5 | RAB2A | P08886 | 475 |
| LHX5 | FOXB1 | Q99853 | 473 |
| LHX5 | BARHL2 | Q9NY43 | 461 |
| LHX5 | FOXG1 | P55315 | 460 |
IntAct
92 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CASP6 | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCK | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | DMWD | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| LHX5 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRIN2C | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | HIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HLA-A | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP2 | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | PMP22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPIB | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAN | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSC1 | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRC2 | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | YWHAG | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | SETDB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | KAT5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN1 | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRPF40A | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX26 | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO3 | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | COQ8A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX5 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNCA | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | LHX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
ESM2 similar proteins: A0JNI8, A2I8Z7, A2PZF9, G5EC36, G5EE86, G5EEA1, P20154, P29673, P29674, P34764, P34765, P36198, P36200, P37137, P48742, P50211, P50212, P50458, P50481, P52889, P53405, P53406, P53407, P53408, P53409, P53411, P53412, P61371, P61372, P61373, P61374, P61375, P61376, P63006, P63007, P63008, Q1LWV4, Q5IS44, Q5IS89, Q68EY3
Diamond homologs: A0JNI8, A2I8Z7, A2PZF9, G5EC36, G5EE86, O14639, O35652, O60663, O88609, O94929, O97581, P20154, P25791, P25800, P25801, P29673, P29674, P34764, P34765, P36198, P36200, P37137, P48742, P50211, P50212, P50458, P50480, P50481, P52889, P53405, P53406, P53407, P53408, P53409, P53410, P53411, P53412, P53413, P53667, P53668
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
44 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
812 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:113467417:CACAC:C | acceptor_gain | 1.0000 |
| 12:113467419:CAC:C | acceptor_gain | 1.0000 |
| 12:113468121:CCGCA:C | donor_loss | 1.0000 |
| 12:113468122:CGCA:C | donor_loss | 1.0000 |
| 12:113468123:GCACC:G | donor_loss | 1.0000 |
| 12:113468124:CA:C | donor_loss | 1.0000 |
| 12:113468125:A:AT | donor_loss | 1.0000 |
| 12:113468126:C:CT | donor_loss | 1.0000 |
| 12:113468401:GACA:G | acceptor_gain | 1.0000 |
| 12:113468405:C:CC | acceptor_gain | 1.0000 |
| 12:113468412:C:CT | acceptor_gain | 1.0000 |
| 12:113468421:C:CT | acceptor_gain | 1.0000 |
| 12:113468422:G:T | acceptor_gain | 1.0000 |
| 12:113469116:TCCTA:T | donor_loss | 1.0000 |
| 12:113469117:CCTAC:C | donor_loss | 1.0000 |
| 12:113469118:CTA:C | donor_loss | 1.0000 |
| 12:113469119:TACC:T | donor_loss | 1.0000 |
| 12:113469120:A:AC | donor_gain | 1.0000 |
| 12:113469120:A:T | donor_loss | 1.0000 |
| 12:113469121:C:CC | donor_gain | 1.0000 |
| 12:113469121:C:CG | donor_loss | 1.0000 |
| 12:113469139:T:TA | donor_gain | 1.0000 |
| 12:113469341:AGCGC:A | acceptor_gain | 1.0000 |
| 12:113469342:GCGC:G | acceptor_gain | 1.0000 |
| 12:113469343:CGC:C | acceptor_gain | 1.0000 |
| 12:113469343:CGCC:C | acceptor_gain | 1.0000 |
| 12:113469344:GC:G | acceptor_gain | 1.0000 |
| 12:113469344:GCCTG:G | acceptor_loss | 1.0000 |
| 12:113469345:CC:C | acceptor_gain | 1.0000 |
| 12:113469345:CCT:C | acceptor_loss | 1.0000 |
AlphaMissense
2641 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:113467387:C:A | R237L | 1.000 |
| 12:113467387:C:G | R237P | 1.000 |
| 12:113467387:C:T | R237Q | 1.000 |
| 12:113467388:G:A | R237W | 1.000 |
| 12:113467388:G:C | R237G | 1.000 |
| 12:113467390:C:G | R236P | 1.000 |
| 12:113467390:C:T | R236H | 1.000 |
| 12:113467391:G:A | R236C | 1.000 |
| 12:113467391:G:T | R236S | 1.000 |
| 12:113467394:C:T | E235K | 1.000 |
| 12:113467395:T:A | K234N | 1.000 |
| 12:113467395:T:G | K234N | 1.000 |
| 12:113467396:T:A | K234I | 1.000 |
| 12:113467396:T:G | K234T | 1.000 |
| 12:113467397:T:C | K234E | 1.000 |
| 12:113467397:T:G | K234Q | 1.000 |
| 12:113467399:G:A | S233F | 1.000 |
| 12:113467399:G:T | S233Y | 1.000 |
| 12:113467400:A:G | S233P | 1.000 |
| 12:113467402:C:A | R232L | 1.000 |
| 12:113467402:C:G | R232P | 1.000 |
| 12:113467402:C:T | R232Q | 1.000 |
| 12:113467403:G:A | R232W | 1.000 |
| 12:113467403:G:C | R232G | 1.000 |
| 12:113467405:C:A | R231L | 1.000 |
| 12:113467405:C:G | R231P | 1.000 |
| 12:113467406:G:C | R231G | 1.000 |
| 12:113467407:G:C | N230K | 1.000 |
| 12:113467407:G:T | N230K | 1.000 |
| 12:113467408:T:A | N230I | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000011920 (12:113471931 G>A,C), RS1000164313 (12:113468584 C>G), RS1000322803 (12:113469028 A>C,G), RS1000346175 (12:113462872 C>A,T), RS1000762607 (12:113462000 A>G), RS1000816951 (12:113461708 T>A,C), RS1000863871 (12:113463063 G>C), RS1000993996 (12:113467574 G>A,C,T), RS1001548395 (12:113473411 T>G), RS1001665988 (12:113464683 T>G), RS1001780092 (12:113468554 C>T), RS1002263753 (12:113465987 A>C,T), RS1002367946 (12:113462752 G>A), RS1002507865 (12:113472687 C>G,T), RS1002635674 (12:113467096 G>C)
Disease associations
OMIM: gene MIM:605992 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003074_26 | Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging) | 1.000000e-06 |
| GCST003139_18 | Glomerular filtration rate in chronic kidney disease | 3.000000e-06 |
| GCST005951_2 | Body mass index | 9.000000e-09 |
| GCST006218_24 | Erosive tooth wear (severe vs non-severe) | 1.000000e-08 |
| GCST009391_1092 | Metabolite levels | 9.000000e-06 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007707 | cerebral amyloid deposition measurement |
| EFO:0004340 | body mass index |
| EFO:0010543 | uridine diphosphate galactose measurement |
| EFO:0010544 | uridine diphosphate glucose measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression, increases methylation | 2 |
| trichostatin A | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Diazinon | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
| Particulate Matter | increases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A3V9 | SEES3-1V human LHX5, clone1 | Embryonic stem cell | Male |
| CVCL_A3W0 | SEES3-1V human LHX5, clone2 | Embryonic stem cell | Male |
| CVCL_A3W1 | SEES3-1V human LHX5, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.